Outcome of Second Line Treatment of Recurrent High- Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study

Volume 24, Issue 5, May 2023, Pages 1507-1511

Kazem Anvari; Mehri Shahabadi; James S Welsh; Seyed Alireza Javadinia; Elham Zarei

• View Article
• PDF 338.01 K

Economic Evaluation of Adding Bevacizumab to Chemotherapy for Metastatic Colorectal Cancer (mCRC) Patients in Indonesia

Volume 22, Issue 6, June 2021, Pages 1921-1926

Erna Kristin; Dwi Endarti; Levina Chandra Khoe; Kartika Widayati Taroeno-Hariadi; Christina Trijayanti; Armansyah Armansyah; Sudigdo Sastroasmoro

• View Article
• PDF 372.88 K

Bevacizumab Regulates Cancer Cell Migration by Activation of STAT3

Volume 16, Issue 15, December 2015, Pages 6501-6506

• View Article
• PDF 1.18 M

Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab

Volume 16, Issue 14, December 2015, Pages 6149-6154

• View Article
• PDF 682.87 K

Treatment of Metastatic Colorectal Cancer With or Without Bevacizumab: Can the Neutrophil/Lymphocyte Ratio Predict the Efficiency of Bevacizumab?

Volume 15, Issue 12, December 2014, Pages 4781-4786

• View Article
• PDF 514.42 K

Efficacy and Safety of Bevacizumab in Chinese Patients with Metastatic Colorectal Cancer

Volume 15, Issue 16, December 2014, Pages 6559-6564

• View Article
• PDF 837.85 K

Anti-VEGF Therapy with Bevacizumab - Limited Cardiovascular Toxicity

Volume 15, Issue 24, December 2014, Pages 10769-10772

• View Article
• PDF 353.44 K

Bevacizumab Concomitant with Chemotherapy is Effective in Treating Chinese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

Volume 15, Issue 14, December 2014, Pages 5945-5950

• View Article
• PDF 843.76 K

Mean Platelet Volume as a Prognostic Marker in Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Combined Chemotherapy

Volume 15, Issue 15, December 2014, Pages 6421-6423

• View Article
• PDF 372.19 K

Clinical Efficacy of Bevacizumab Concomitant with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer

Volume 15, Issue 8, August 2014, Pages 3447-3450

• View Article
• PDF 476.08 K

Xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two-Institutions

Volume 14, Issue 4, April 2013, Pages 2283-2288

• View Article
• PDF 416.09 K

Risk of Serious Neutropenic Events in Cancer Patients Treated with Bevacizumab: A Meta-analysis

Volume 14, Issue 4, April 2013, Pages 2453-2459

• View Article
• PDF 603.11 K

Analysis of PTEN, VEGF, HER2 and P53 Status in Determining Colorectal Cancer Benefit from Bevacizumab Therapy

Volume 13, Issue 12, December 2012, Pages 6397-6401

• View Article
• PDF 533.78 K

Prognostic Factors for Overall Survival in Patients With Metastatic Colorectal Carcinoma Treated With Vascular Endothelial Growth Factor-Targeting Agents

Volume 13, Issue 3, March 2012, Pages 1059-1063

• View Article
• PDF 981.2 K